Success Metrics

Clinical Success Rate
70.0%

Based on 7 completed trials

Completion Rate
70%(7/10)
Active Trials
0(0%)
Results Posted
86%(6 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_4
2
18%
Ph phase_1
1
9%
Ph phase_2
5
45%
Ph phase_3
1
9%
Ph not_applicable
2
18%

Phase Distribution

1

Early Stage

5

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
5(45.5%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(7)
Terminated(3)

Detailed Status

Completed7
Terminated3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
70.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 25 (45.5%)
Phase 31 (9.1%)
Phase 42 (18.2%)
N/A2 (18.2%)

Trials by Status

completed764%
not_yet_recruiting19%
terminated327%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_4

tSCI Contrast Enhanced Ultrasound Study

NCT04056988
not_yet_recruitingphase_3

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

NCT06024772
completedphase_2

SHAPE for ICP Assessment

NCT06571786
terminatednot_applicable

Use of Reactivated DEFINITY or LUMASON in Patients Undergoing Rest or Stress Echocardiography

NCT02950493
completedphase_2

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau

NCT03907657
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT04056988Phase 4

tSCI Contrast Enhanced Ultrasound Study

Completed
NCT06024772Phase 3

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Not Yet Recruiting
NCT06571786Phase 2

SHAPE for ICP Assessment

Completed
NCT02950493Not Applicable

Use of Reactivated DEFINITY or LUMASON in Patients Undergoing Rest or Stress Echocardiography

Terminated
NCT03907657Phase 2

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau

Completed
NCT04021238Phase 2

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

Completed
NCT03196076Phase 2

Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension

Completed
NCT02684435Phase 2

Contrast-enhanced Ultrasound of the Kidney

Completed
NCT02880137Phase 4

Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy

Completed
NCT01391039Not Applicable

Diagnostic Study of Early Breast Cancer Using Ultrasound

Terminated
NCT00507806Phase 1

Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke

Terminated

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11